Compound

Immunoxel

Names
Chemical Class:
Name of Target:
Description

Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.

Batbold U, Butov DO, Kutsyna GA, Damdinpurev N, Grinishina EA, Mijiddorj O, Kovolev ME, Baasanjav K, Butova TS, Sandagdorj M, Batbold O, Tseveendorj A, Chunt E, Zaitzeva SI, Stepanenko HL, Makeeva NI, Mospan IV, Pylypchuk VS, Rowe JL, Nyasulu P, Jirathitikal V, Bain AI, Tarakanovskaya MG, Bourinbaiar AS.

 

Immunitor LLC., Peace Avenue 25, Ulaanbaatar, Mongolia

Immunotherapy. 2017 Jan;9(1):13-24. doi: 10.2217/imt-2016-0079.

Immunoxel is a water-alcohol extract of aloe (Aloe arborescens), licorice (Glycyrrhiza glabra), dog rose fruit (Rosa canina), oregano (Oreganum majorana), sage (Salvia officinalis), thyme (Thymus vulgaris), fennel (Foeniculum vulgare), dandelion (Taraxacum officinale), purple coneflower (Echinacea purpurea), nettle (Urtica dioica), marigold (Calendula officinalis), greater plantain (Plantago major), wormwood (Artemisia sp.), common knotgrass (Polygonum aviculare), yarrow (Achillea millefolium), centaury (Centaurium erythraea), elecampane (Inula helenium), tormentil (Potentilla erecta), cudweed (Gnaphalium uliginosum),three-lobe beggarticks (Bidens tripartita), Siberian golden root (Rhodiola rosea), chaga (Inonotus obliquus), snowball tree berries (Viburnum opulus), seabuckthorn berries (Hippophae rhamnoides) and juniper berries (Juniperus communis) according to standardized manufacturing process using each plant at a specific proportion as approved by the Ministry of Health of Ukraine in 2006 (TUU 15.8–23732912–016:2006). Immunoxel was produced by a Ukrainian company Ekomed in Kiev, Ukraine.